|

Engineering Immune Organoids to Study Pediatric Cancer

RECRUITINGN/ASponsored by Gustave Roussy, Cancer Campus, Grand Paris
Actively Recruiting
PhaseN/A
SponsorGustave Roussy, Cancer Campus, Grand Paris
Started2023-05-12
Est. completion2028-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05890781

Summary

To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Age at diagnosis ≤ 25 years except for patients with malignant gliomas and renal tumors for whom no upper age limit is applied
* Medical suspicion or diagnosis of one of the following diseases, regardless of stage:
* Brain tumors
* Renal tumors
* Neuroblastoma
* Sarcomas
* Adult patient or parents or guardians should understand, sign and date the appropriate written informed consent from prior to any protocol-specific procedures performed. Patient should be able and willing to comply with study visits and procedures as per protocol.
* Affiliated to a social security system or beneficiary of the same.

Exclusion Criteria:

* Any histology not mentioned in the inclusion criteria
* Adult patient or parents/guardians incapable/incapable of giving its/their consent
* Patients deprived of their liberty by a judicial or administrative decision

Conditions5

Brain TumorCancerKidney TumorNeuroblastomaSarcoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.